While differences were observed for the serum ANCA titer in relapsing and non-relapsing patients, monitoring in vitro PR3-ANCA IgG production does not improve relapse prediction in GPA patients. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.